These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22425267)

  • 41. Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life.
    Newman DM; Dorian P; Paquette M; Sulke N; Gold MR; Schwartzman DS; Schaaf K; Wood K; Johnson L;
    Am Heart J; 2003 May; 145(5):841-6. PubMed ID: 12766741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of ventricular arrhythmia burden, therapeutic interventions, and survival, in patients < 75 and patients >or= 75 years of age treated with implantable cardioverter defibrillators.
    Ermis C; Zhu AX; Vanheel L; Sakaguchi RN; Lurie KG; Lu F; Benditt DG
    Europace; 2007 May; 9(5):270-4. PubMed ID: 17371804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators.
    DeMaso DR; Lauretti A; Spieth L; van der Feen JR; Jay KS; Gauvreau K; Walsh EP; Berul CI
    Am J Cardiol; 2004 Mar; 93(5):582-7. PubMed ID: 14996583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sexual dysfunction, depression and quality of life in male implantable cardioverter defibrillator (ICD) recipients--with and without shock delivery].
    Shiyovich A; Ben Zion IZ; Plakht Y; Amit G; Grosbard A; Katz A
    Harefuah; 2007 Aug; 146(8):594-8, 647. PubMed ID: 17853553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adolescents with implantable cardioverter defibrillators: a patient and parent perspective.
    Rahman B; Macciocca I; Sahhar M; Kamberi S; Connell V; Duncan RE
    Pacing Clin Electrophysiol; 2012 Jan; 35(1):62-72. PubMed ID: 21967596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implantable cardiac device procedures in older patients: use and in-hospital outcomes.
    Swindle JP; Rich MW; McCann P; Burroughs TE; Hauptman PJ
    Arch Intern Med; 2010 Apr; 170(7):631-7. PubMed ID: 20386008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality of life and psychological status of patients with implantable cardioverter defibrillators.
    Thomas SA; Friedmann E; Kao CW; Inguito P; Metcalf M; Kelley FJ; Gottlieb SS
    Am J Crit Care; 2006 Jul; 15(4):389-98. PubMed ID: 16823016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal changes in quality of life following ICD implant and the impact of age, gender, and ICD shocks: observations from the INTRINSIC RV trial.
    Gopinathannair R; Lerew DR; Cross NJ; Sears SF; Brown S; Olshansky B
    J Interv Card Electrophysiol; 2017 Apr; 48(3):291-298. PubMed ID: 28220279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    Hickey K; Curtis AB; Lancaster S; Larsen G; Warwick D; McAnulty J; Mitchell LB
    Am Heart J; 2001 Jul; 142(1):99-104. PubMed ID: 11431664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review.
    Burke JL; Hallas CN; Clark-Carter D; White D; Connelly D
    Br J Health Psychol; 2003 May; 8(Pt 2):165-78. PubMed ID: 12804331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Costs and quality-of-life effects of implantable cardioverter-defibrillators.
    Groeneveld PW; Matta MA; Suh JJ; Heidenreich PA; Shea JA
    Am J Cardiol; 2006 Nov; 98(10):1409-15. PubMed ID: 17134641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients.
    Sears SF; Sowell LD; Kuhl EA; Kovacs AH; Serber ER; Handberg E; Kneipp SM; Zineh I; Conti JB
    Pacing Clin Electrophysiol; 2007 Jul; 30(7):858-64. PubMed ID: 17584267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychological effects of implantable cardioverter-defibrillator leads under advisory.
    Heatherly SJ; Simmons T; Fitzgerald DM; Mitchell M
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):694-9. PubMed ID: 21410721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices.
    Lampert R
    Clin Geriatr Med; 2012 Nov; 28(4):693-702. PubMed ID: 23101578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.